Sep 15, 2022 / 04:20PM GMT
Joshua Charles Pokrzywinski - Morgan Stanley, Research Division - Equity Analyst
All right. Good morning, everybody. Welcome back. We're going to keep things rolling along here with Dover, and I'm pleased to have on stage with me Richard Tobin, President and CEO. Rich, thanks for joining us. Always a pleasure. I know you have some slides to go through first. I'll let you run through those, and we'll dive into it.
Richard Joseph Tobin - Dover Corporation - President, CEO & Director
Great. Thanks, Josh. Let's see if I can get these slides to move forward. I guess everybody wants to start with a little bit of an overall trading conditions update of where we are.
Trading conditions remain robust against the majority of the portfolio. We continue to book well, especially in the businesses that are driven by current secular growth trends, heat exchangers, clean energy components, waste management, plastics processing, recycling, et cetera. Biopharma demand remains consistent with what we've seen in the trends through H1. So we look at this as something as
Dover Corp at Morgan Stanley Laguna Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers